Edition:
United States

Myriad Genetics Inc (MYGN.OQ)

MYGN.OQ on NASDAQ Stock Exchange Global Select Market

46.93USD
4:00pm EDT
Change (% chg)

$0.66 (+1.43%)
Prev Close
$46.27
Open
$46.49
Day's High
$47.37
Day's Low
$46.49
Volume
167,053
Avg. Vol
257,067
52-wk High
$50.43
52-wk Low
$27.23

Chart for

About

Myriad Genetics, Inc. is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is... (more)

Overall

Beta: 0.51
Market Cap(Mil.): $3,281.49
Shares Outstanding(Mil.): 70.92
Dividend: --
Yield (%): --

Financials

  MYGN.OQ Industry Sector
P/E (TTM): 33.85 47.86 32.69
EPS (TTM): 1.37 -- --
ROI: 9.35 8.48 12.72
ROE: 11.16 12.20 14.85

BRIEF-Myriad Genetics Reports Q3 GAAP Earnings Per Share $0.16

* MYRIAD GENETICS REPORTS FISCAL THIRD-QUARTER 2018 FINANCIAL RESULTS

May 08 2018

BRIEF-Myriad Receives Pre Market Approval For Its Bracanalysis Diagnostic System In Japan

April 2 Myriad Genetics Inc - ‍Astrazeneca And Merck Are Seeking Approval Of Lynparza In Japan For Treating Patients With Brca :

Apr 02 2018

Earnings vs. Estimates